A randomized, double-blind, placebo-controlled, dose finding trial using sublingual alfentanil to alleviate pain associated with a prostate biopsy procedure

Trial Profile

A randomized, double-blind, placebo-controlled, dose finding trial using sublingual alfentanil to alleviate pain associated with a prostate biopsy procedure

Completed
Phase of Trial: Phase II/III

Latest Information Update: 26 Oct 2013

At a glance

  • Drugs Alfentanil (Primary)
  • Indications Procedural pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Aug 2013 Primary endpoint 'Worst pain intensity measured by Numerical-Rating-Scale' has been met.
    • 28 Aug 2013 Results published in an Orexo media release.
    • 18 Jul 2013 Status changed from recruiting to completed, according to an Orexo media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top